These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13948810)

  • 1. Quantitative electroencephalography in man as a measure of CNS stimulation.
    GOLDSTEIN L; MURPHREE HB; PFEIFFER CC
    Ann N Y Acad Sci; 1963 Jul; 107():1045-56. PubMed ID: 13948810
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration of the "group toxicity" of certain monoamino-oxidase inhibitors. Comparison of their mode of action with that of amphetamine].
    HALPERN BN; DRUDI-BARACCO C; BESSIRARD D
    C R Seances Soc Biol Fil; 1962; 156():1238-45. PubMed ID: 13952219
    [No Abstract]   [Full Text] [Related]  

  • 3. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECTS OF RESERPINE PRE-TREATMENT ON THE PROTECTIVE ACTION OF AMPHETAMINE AND PHENOXYPROPAZINE IN THE PHENYLBENZOQUINONE-INDUCED WRITHING SYNDROME IN MICE.
    DAVIS RA; HORLINGTON M
    Nature; 1964 Jan; 201():306-7. PubMed ID: 14110466
    [No Abstract]   [Full Text] [Related]  

  • 5. [CHEESE AND THERAPEUTICS. APROPOS OF ACCIDENTS CAUSED BY MONOAMINE OXIDASE INHIBITORS].
    GOSSET J
    Concours Med; 1964 Jul; 86():4527-9. PubMed ID: 14181357
    [No Abstract]   [Full Text] [Related]  

  • 6. HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS.
    BLACKWELL B
    Lancet; 1963 Oct; 2(7313):849-50. PubMed ID: 14056007
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect upon the analgesic action of reserpine of central nervous system stimulants and drugs affecting the metabolism of catechol- and indole-amines.
    LEME JG; ROCHA E SILVA M
    J Pharm Pharmacol; 1963 Jul; 15():454-60. PubMed ID: 13929554
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECTS OF ENZYME INHIBITORS ON THE ADRENERGIC MECHANISMS IN ISOLATED VAS DEFERENS PREPARATION.
    BHARGAVA KP; KAR K; PARMAR SS
    Life Sci (1962); 1963 Dec; 12():989-92. PubMed ID: 14100232
    [No Abstract]   [Full Text] [Related]  

  • 9. MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS.
    GOLDBERG LI
    JAMA; 1964 Nov; 190():456-62. PubMed ID: 14197995
    [No Abstract]   [Full Text] [Related]  

  • 10. THE EFFECT OF DRUGS ON THE ELECTROENCEPHALOGRAM OF MAN.
    BRAZIER MA
    Clin Pharmacol Ther; 1964; 5():102-16. PubMed ID: 14107115
    [No Abstract]   [Full Text] [Related]  

  • 11. VASCULAR CRISES ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS.
    BETHUNE HC; BURRELL RH; CULPAN RH; OGG GJ
    Am J Psychiatry; 1964 Sep; 121():245-8. PubMed ID: 14233735
    [No Abstract]   [Full Text] [Related]  

  • 12. [SUCCINET REFLECTIONS ON THE CLINICAL USE OF ANTIDEPRESSIVE AGENTS].
    BOBON J; GOFFIOUL F; COLLARD J; BREULET M
    Encephale; 1964; 53():479-84. PubMed ID: 14222722
    [No Abstract]   [Full Text] [Related]  

  • 13. TREATMENT OF DEPRESSION.
    PARE CM
    Lancet; 1965 May; 1(7392):923-5. PubMed ID: 14275707
    [No Abstract]   [Full Text] [Related]  

  • 14. ELECTROENCEPHALOGRAPHIC AND BEHAVIORAL ANALYSIS OF DRUG EFFECTS ON AN INSTRUMENTAL REWARD DISCRIMINATION IN RABBITS.
    MCGAUGH JL; DEBARAN L; LONGO VG
    Psychopharmacologia; 1963 Apr; 4():126-38. PubMed ID: 14050418
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of some drugs on the electrical activity of the brain.
    BRADLEY PB; ELKES J
    Brain; 1957 Mar; 80(1):77-117. PubMed ID: 13412997
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.
    Sherry RL; Rauw G; McKenna KF; Paetsch PR; Coutts RT; Baker GB
    J Affect Disord; 2000 Dec; 61(1-2):23-9. PubMed ID: 11099737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination Between Drug Abuse and Medical Therapy: Case report of a tranylcypromine overdose-related fatality.
    Akhgari M; Jokar F; Etemadi-Aleagha A; Ghasemi A
    Sultan Qaboos Univ Med J; 2017 May; 17(2):e213-e217. PubMed ID: 28690895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One fatal and one nonfatal intoxication with tranylcypromine. Absence of amphetamines as metabolites.
    Iwersen S; Schmoldt A
    J Anal Toxicol; 1996 Sep; 20(5):301-4. PubMed ID: 8872238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE.
    HILL HE; HAERTZEN CA; WOLBACH AB; MINER EJ
    Psychopharmacologia; 1963 May; 4():167-83. PubMed ID: 14048539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.